These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11473383)

  • 21. Recombinant human cytochrome P450 1B1 expression in Escherichia coli.
    Shimada T; Wunsch RM; Hanna IH; Sutter TR; Guengerich FP; Gillam EM
    Arch Biochem Biophys; 1998 Sep; 357(1):111-20. PubMed ID: 9721189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
    Kim D; Guengerich FP
    Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
    Badawi AF; Cavalieri EL; Rogan EG
    Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes.
    Hammons GJ; Milton D; Stepps K; Guengerich FP; Tukey RH; Kadlubar FF
    Carcinogenesis; 1997 Apr; 18(4):851-4. PubMed ID: 9111224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
    Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
    Jerabek P; Martinek V; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C; Eugster HP; Würgler FE
    Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
    Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
    Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
    Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
    Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
    Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
    Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver.
    Mori Y; Koide A; Kobayashi Y; Furukawa F; Hirose M; Nishikawa A
    Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
    Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
    Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
    Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
    Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
    Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
    Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
    Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
    Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of high sucrose diet on cytochrome P450 1A and heterocyclic amine mutagenesis.
    Peters LP; Teel RW
    Anticancer Res; 2003; 23(1A):399-403. PubMed ID: 12680239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
    Josephy PD; Evans DH; Parikh A; Guengerich FP
    Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.